In previous randomized trials, 18F-PSMA PET/CT was shown to have excellent specificity for detecting pelvic lymph node metastasis [70] and to have high detection rates for assessing PCa recurrence, even in patients who had low PSA levels [71]. Here, FOLH1 is linked to posterior cortical atrophy.